text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 375815-87-5 | Product Number: V0168

Varenicline Tartrate

Purity: >95.0%(T)
  • 7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-Dihydroxysuccinic Acid
  • 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine Tartrate
19   Contact Us
19   Contact Us

* Please contact our distributors or TCI to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.

Product Number V0168
Purity / Analysis Method >95.0%(T)
Molecular Formula / Molecular Weight C__1__3H__1__3N__3·C__4H__6O__6 = 361.35 
Physical State (20 deg.C) Solid
Store Under Inert Gas Store under inert gas
Condition to Avoid Air Sensitive
CAS RN 375815-87-5
Reaxys Registry Number 14347664
PubChem Substance ID 468593111
MDL Number


Appearance White to Light yellow to Light orange powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Neutralization titration) min. 95.0 %
Water max. 5.0 %
Properties (reference)
Melting Point 215 °C
Pictogram Pictogram
Signal Word Warning
Hazard Statements H410 : Very toxic to aquatic life with long lasting effects.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P273 : Avoid release to the environment.
P391 : Collect spillage.
Related Laws:
RTECS# PC5072000
Transport Information:
UN Number UN3077
Class 9
Packing Group III
H.S.code* 2933.39-000
*This code is applied to the products when TCI exports from Japan and not for import in your country.
Varenicline Tartrate: A Partial Agonist/Antagonist with Affinity and Selectivity for α4β2 Nicotinic Acetylcholine Receptors

Varenicline tartrate is a partial agonist/antagonist with affinity and selectivity for α4β2 nicotinic acetylcholine receptors. Varenicline binds to α4β2 neuronal nicotinic acetylcholine receptors and stimulates receptor-mediated activity, but at a significantly lower level than nicotine. In other words, varenicline blocks the ability of nicotine to the receptors (antagonist) and thus to stimulate partially the central nervous mesolimbic dopamine system (partial agonist). In clinical, varenicline tartrate is used as an anti-smoking agent. This receptor stimulation is thought to reduce the withdrawal symptoms associated with smoking cessation and the craving for cigarettes. (The product is for research purpose only.)


Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents